Oligomeric structure of the α1b-adrenoceptor: Comparisons with rhodopsin

[1]  J. Rossier,et al.  Constitutive Activation Drives Compartment-Selective Endocytosis and Axonal Targeting of Type 1 Cannabinoid Receptors , 2006, The Journal of Neuroscience.

[2]  K. Palczewski,et al.  Rhodopsin self-associates in asolectin liposomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Khorana,et al.  Opsin is present as dimers in COS1 cells: identification of amino acids at the dimeric interface. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Eidne,et al.  Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET) , 2006, Nature Methods.

[5]  Marta Filizola,et al.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Michel Bouvier,et al.  Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.

[7]  Shelagh Wilson,et al.  The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. , 2005, The Biochemical journal.

[8]  G. Milligan,et al.  β-Arrestin-Dependent Spontaneous α1a-Adrenoceptor Endocytosis Causes Intracellular Transportation of α-Blockers via Recycling Compartments , 2005, Molecular Pharmacology.

[9]  Alfonso Valencia,et al.  A framework for computational and experimental methods: Identifying dimerization residues in CCR chemokine receptors , 2005, ECCB/JBI.

[10]  G. Milligan,et al.  Beta-arrestin-dependent spontaneous alpha1a-adrenoceptor endocytosis causes intracellular transportation of alpha-blockers via recycling compartments. , 2005, Molecular pharmacology.

[11]  Vladislav V Verkhusha,et al.  Three-chromophore FRET microscopy to analyze multiprotein interactions in living cells , 2004, Nature Methods.

[12]  G. Milligan,et al.  Multiple Interactions between Transmembrane Helices Generate the Oligomeric α1b-Adrenoceptor , 2004, Molecular Pharmacology.

[13]  Beilei Lei,et al.  Cellular Trafficking of Human α1a-Adrenergic Receptors Is Continuous and Primarily Agonist-Independent , 2004, Molecular Pharmacology.

[14]  J. Rossier,et al.  Constitutive Endocytic Cycle of the CB1 Cannabinoid Receptor* , 2004, Journal of Biological Chemistry.

[15]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[16]  A. Engel,et al.  The G protein‐coupled receptor rhodopsin in the native membrane , 2004, FEBS letters.

[17]  Graeme Milligan,et al.  Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  Manfred Burghammer,et al.  Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.

[19]  S. Enna.  Recent advances in alpha1-adrenoceptor pharmacology. , 2004, Pharmacology & therapeutics.

[20]  K. Blumer,et al.  Oligomerization, Biogenesis, and Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 1 of a Yeast G Protein-coupled Receptor* , 2003, Journal of Biological Chemistry.

[21]  K. Minneman,et al.  Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. , 2003, Molecular pharmacology.

[22]  Graeme Milligan,et al.  Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins* , 2003, Journal of Biological Chemistry.

[23]  Horst Vogel,et al.  Oligomerization of the α1a- and α1b-Adrenergic Receptor Subtypes , 2003, Journal of Biological Chemistry.

[24]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[25]  Gozoh Tsujimoto,et al.  Recent advances in α1-adrenoceptor pharmacology , 2003 .

[26]  G. Milligan,et al.  CypHer 5: a generic approach for measuring the activation and trafficking of G protein-coupled receptors in live cells. , 2003, Assay and drug development technologies.

[27]  Lei Shi,et al.  The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.

[28]  H. Vogel,et al.  Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. , 2003, The Journal of biological chemistry.

[29]  G. Milligan,et al.  Measurement of Agonist-Dependent and -Independent Signal Initiation of α1b-Adrenoceptor Mutants by Direct Analysis of Guanine Nucleotide Exchange on the G Protein Gα11 , 2002, Journal of Pharmacology and Experimental Therapeutics.

[30]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[31]  B. Gowen,et al.  Three-dimensional structure of an invertebrate rhodopsin and basis for ordered alignment in the photoreceptor membrane. , 2001, Journal of molecular biology.

[32]  M. Piascik,et al.  α1-Adrenergic Receptors: New Insights and Directions , 2001 .

[33]  M. Bouvier,et al.  Newly Synthesized Human δ Opioid Receptors Retained in the Endoplasmic Reticulum Are Retrotranslocated to the Cytosol, Deglycosylated, Ubiquitinated, and Degraded by the Proteasome* , 2001, The Journal of Biological Chemistry.

[34]  M. Piascik,et al.  Alpha1-adrenergic receptors: new insights and directions. , 2001, The Journal of pharmacology and experimental therapeutics.

[35]  Krzysztof Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Science.

[36]  J. Pediani,et al.  Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites. , 2000, The Journal of pharmacology and experimental therapeutics.

[37]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.